Summary
- Current Price
- As of today, RGEN price is $180.29, up +2.23% on
- Current Price All-Time High
- RGEN price is currently -44.92% below its historical high of $327.32 set on
- Market Cap
- RGEN current market cap is $10B, up +48.80% over the past 365 days
- PE Ratio
- RGEN current PE ratio is 245.73
- Revenue
- RGEN current annual revenue is $738.26M, up +16.36% year-over-year
- Next Earnings
- The next earnings release for RGEN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Repligen Corporation |
| Ticker | NASDAQ: RGEN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | repligen.com |
| Employees | 1,778 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $180.29 | |
| Price, 1D Change | +2.23% | |
| $10B | ||
| - | ||
| 245.73 | ||
| 1.23 | ||
| $738.26M | ||
| Revenue, 1Y Change | +16.36% | |
| $0.86 | ||
| EPS, 1Y Change | +289.52% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $0.86 | ||
| EPS Estimate | $2.06 | N/A |
| EPS Est. Change | +138.81% | N/A |
| $738.26M | ||
| Revenue Estimate | $827.04M | N/A |
| Revenue Est. Change | +12.03% | N/A |
| Current Price | $180.29 | |
| Price Target | $185.00 | - |
| Price Tgt. Change | +2.61% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.53 | -$0.46 | -129.72% | |
| $1.67 | $0.86 | -48.18% | |
| $2.06 | N/A | +138.81% | |
| $2.64 | N/A | +205.34% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $634.06M | $634.44M | +0.06% | |
| $732.50M | $738.26M | +0.79% | |
| $827.04M | N/A | +12.03% | |
| $969.23M | N/A | +31.29% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $180.29 | |
| $140.46 | ||
| $145.94 | ||
| $138.35 | ||
| $148.30 | ||
| $9.02 | ||
| 1.23 | ||
| $7.60 | ||
| 75.79 | ||
| 34.41% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $738.26M | ||
| $0.86 | ||
| $347.62M | ||
| 47.50% | ||
| $59.58M | ||
| 8.07% | ||
| $48.89M | ||
| 6.62% | ||
| $138.32M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.33 | ||
| 8.37 | ||
| 7.12 | ||
| - | ||
| 7 | ||
| 8.18 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 245.73 | ||
| 12.96 | ||
| 4.82 | ||
| 58.18 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $2.11B | ||
| $767.63M | ||
| $2.95B | ||
| $1.14B | ||
| $843.57M | ||
| $135.83M | ||
| $689.95M | ||
| $21.56M | ||
| $30.01M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $689.36M | ||
| $288.05M | ||
| $390.63M | ||
| $0.00 | ||
| $96.96M | ||
| $0.00 | ||
| $13.49M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $117.42M | ||
| -$298.47M | ||
| -$15.21M | ||
| $25.73M | ||
| $91.69M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| JP Morgan | → | |
| Benchmark | → | |
| Evercore ISI Group | → | |
| HSBC | → | |
| JP Morgan | → | |
| Barclays | → | |
| Canaccord Genuity | → | |
| Roth Capital | ||
| Barclays | → |
Analyst sentiment
Institutional ownership
No data
Screeners with RGEN
FAQ
- What is the ticker symbol for Repligen Corporation?
- The ticker symbol for Repligen Corporation is NASDAQ:RGEN
- Does Repligen Corporation pay dividends?
- No, Repligen Corporation does not pay dividends
- What sector is Repligen Corporation in?
- Repligen Corporation is in the Healthcare sector
- What industry is Repligen Corporation in?
- Repligen Corporation is in the Medical Instruments & Supplies industry
- What country is Repligen Corporation based in?
- Repligen Corporation is headquartered in United States
- When did Repligen Corporation go public?
- Repligen Corporation initial public offering (IPO) was on April 29, 1986
- Is Repligen Corporation in the S&P 500?
- No, Repligen Corporation is not included in the S&P 500 index
- Is Repligen Corporation in the NASDAQ 100?
- No, Repligen Corporation is not included in the NASDAQ 100 index
- Is Repligen Corporation in the Dow Jones?
- No, Repligen Corporation is not included in the Dow Jones index
- When was Repligen Corporation last earnings report?
- Repligen Corporation's most recent earnings report was on July 28, 2026
- When does Repligen Corporation report earnings?
- The next expected earnings date for Repligen Corporation is November 3, 2026
Data Sources & References
- RGEN Official Website www.repligen.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/730272/000119312526076528/0001193125-26-076528-index.htm
- RGEN Profile on Yahoo Finance finance.yahoo.com/quote/RGEN
- RGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgen
